Across a range of genetically engineered, patient-derived, and orthoptic NSCLC models, [18F]FSPG retention was increased in tumours with NRF2 activation compared to tumours with a normal-functioning NRF2/KEAP1 axis. Here, NFE2L2 is linked to non-small cell lung carcinoma.